IBDEI0UY ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,40659,1,4,0)
 ;;=4^L21.8
 ;;^UTILITY(U,$J,358.3,40659,2)
 ;;=^303310
 ;;^UTILITY(U,$J,358.3,40660,0)
 ;;=L20.89^^119^1742^7
 ;;^UTILITY(U,$J,358.3,40660,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40660,1,3,0)
 ;;=3^Dermatitis,Atopic
 ;;^UTILITY(U,$J,358.3,40660,1,4,0)
 ;;=4^L20.89
 ;;^UTILITY(U,$J,358.3,40660,2)
 ;;=^5009112
 ;;^UTILITY(U,$J,358.3,40661,0)
 ;;=E08.622^^119^1742^23
 ;;^UTILITY(U,$J,358.3,40661,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40661,1,3,0)
 ;;=3^Diabetes d/t Underlying Condition w/ Skin Ulcer
 ;;^UTILITY(U,$J,358.3,40661,1,4,0)
 ;;=4^E08.622
 ;;^UTILITY(U,$J,358.3,40661,2)
 ;;=^5002535
 ;;^UTILITY(U,$J,358.3,40662,0)
 ;;=T81.31XA^^119^1742^26
 ;;^UTILITY(U,$J,358.3,40662,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40662,1,3,0)
 ;;=3^Disruption External Surgical Wound NEC,Init Encntr
 ;;^UTILITY(U,$J,358.3,40662,1,4,0)
 ;;=4^T81.31XA
 ;;^UTILITY(U,$J,358.3,40662,2)
 ;;=^5054470
 ;;^UTILITY(U,$J,358.3,40663,0)
 ;;=L26.^^119^1742^8
 ;;^UTILITY(U,$J,358.3,40663,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40663,1,3,0)
 ;;=3^Dermatitis,Exfoliative
 ;;^UTILITY(U,$J,358.3,40663,1,4,0)
 ;;=4^L26.
 ;;^UTILITY(U,$J,358.3,40663,2)
 ;;=^263886
 ;;^UTILITY(U,$J,358.3,40664,0)
 ;;=L98.1^^119^1742^9
 ;;^UTILITY(U,$J,358.3,40664,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40664,1,3,0)
 ;;=3^Dermatitis,Factitial
 ;;^UTILITY(U,$J,358.3,40664,1,4,0)
 ;;=4^L98.1
 ;;^UTILITY(U,$J,358.3,40664,2)
 ;;=^186781
 ;;^UTILITY(U,$J,358.3,40665,0)
 ;;=L30.3^^119^1742^11
 ;;^UTILITY(U,$J,358.3,40665,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40665,1,3,0)
 ;;=3^Dermatitis,Infective
 ;;^UTILITY(U,$J,358.3,40665,1,4,0)
 ;;=4^L30.3
 ;;^UTILITY(U,$J,358.3,40665,2)
 ;;=^5009156
 ;;^UTILITY(U,$J,358.3,40666,0)
 ;;=L56.2^^119^1742^19
 ;;^UTILITY(U,$J,358.3,40666,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40666,1,3,0)
 ;;=3^Dermatitis,Photocontact
 ;;^UTILITY(U,$J,358.3,40666,1,4,0)
 ;;=4^L56.2
 ;;^UTILITY(U,$J,358.3,40666,2)
 ;;=^5009216
 ;;^UTILITY(U,$J,358.3,40667,0)
 ;;=L71.0^^119^1742^18
 ;;^UTILITY(U,$J,358.3,40667,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40667,1,3,0)
 ;;=3^Dermatitis,Perioral
 ;;^UTILITY(U,$J,358.3,40667,1,4,0)
 ;;=4^L71.0
 ;;^UTILITY(U,$J,358.3,40667,2)
 ;;=^5009274
 ;;^UTILITY(U,$J,358.3,40668,0)
 ;;=L23.1^^119^1742^2
 ;;^UTILITY(U,$J,358.3,40668,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40668,1,3,0)
 ;;=3^Dermatitis,Allergic Contact d/t Adhesives
 ;;^UTILITY(U,$J,358.3,40668,1,4,0)
 ;;=4^L23.1
 ;;^UTILITY(U,$J,358.3,40668,2)
 ;;=^5009116
 ;;^UTILITY(U,$J,358.3,40669,0)
 ;;=L23.81^^119^1742^3
 ;;^UTILITY(U,$J,358.3,40669,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40669,1,3,0)
 ;;=3^Dermatitis,Allergic Contact d/t Animal Dander
 ;;^UTILITY(U,$J,358.3,40669,1,4,0)
 ;;=4^L23.81
 ;;^UTILITY(U,$J,358.3,40669,2)
 ;;=^5009123
 ;;^UTILITY(U,$J,358.3,40670,0)
 ;;=L23.0^^119^1742^5
 ;;^UTILITY(U,$J,358.3,40670,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40670,1,3,0)
 ;;=3^Dermatitis,Allergic Contact d/t Metals
 ;;^UTILITY(U,$J,358.3,40670,1,4,0)
 ;;=4^L23.0
 ;;^UTILITY(U,$J,358.3,40670,2)
 ;;=^5009115
 ;;^UTILITY(U,$J,358.3,40671,0)
 ;;=B00.1^^119^1742^10
 ;;^UTILITY(U,$J,358.3,40671,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40671,1,3,0)
 ;;=3^Dermatitis,Herpes Simplex
 ;;^UTILITY(U,$J,358.3,40671,1,4,0)
 ;;=4^B00.1
 ;;^UTILITY(U,$J,358.3,40671,2)
 ;;=^5000468
 ;;^UTILITY(U,$J,358.3,40672,0)
 ;;=L24.0^^119^1742^13
 ;;^UTILITY(U,$J,358.3,40672,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40672,1,3,0)
 ;;=3^Dermatitis,Irritant Contact d/t Detergents
 ;;^UTILITY(U,$J,358.3,40672,1,4,0)
 ;;=4^L24.0
 ;;^UTILITY(U,$J,358.3,40672,2)
 ;;=^5009126
 ;;^UTILITY(U,$J,358.3,40673,0)
 ;;=L24.81^^119^1742^14
 ;;^UTILITY(U,$J,358.3,40673,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40673,1,3,0)
 ;;=3^Dermatitis,Irritant Contact d/t Metals
 ;;^UTILITY(U,$J,358.3,40673,1,4,0)
 ;;=4^L24.81
 ;;^UTILITY(U,$J,358.3,40673,2)
 ;;=^5009134
 ;;^UTILITY(U,$J,358.3,40674,0)
 ;;=L24.2^^119^1742^15
 ;;^UTILITY(U,$J,358.3,40674,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40674,1,3,0)
 ;;=3^Dermatitis,Irritant Contact d/t Solvents
 ;;^UTILITY(U,$J,358.3,40674,1,4,0)
 ;;=4^L24.2
 ;;^UTILITY(U,$J,358.3,40674,2)
 ;;=^5009128
 ;;^UTILITY(U,$J,358.3,40675,0)
 ;;=E08.620^^119^1742^22
 ;;^UTILITY(U,$J,358.3,40675,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40675,1,3,0)
 ;;=3^Diabetes d/t Underlying Condition w/ DM Dermatitis
 ;;^UTILITY(U,$J,358.3,40675,1,4,0)
 ;;=4^E08.620
 ;;^UTILITY(U,$J,358.3,40675,2)
 ;;=^5002533
 ;;^UTILITY(U,$J,358.3,40676,0)
 ;;=E08.621^^119^1742^24
 ;;^UTILITY(U,$J,358.3,40676,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40676,1,3,0)
 ;;=3^Diabetes d/t Underlying Conditions w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,40676,1,4,0)
 ;;=4^E08.621
 ;;^UTILITY(U,$J,358.3,40676,2)
 ;;=^5002534
 ;;^UTILITY(U,$J,358.3,40677,0)
 ;;=T81.33XA^^119^1742^27
 ;;^UTILITY(U,$J,358.3,40677,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40677,1,3,0)
 ;;=3^Disruption Traumatic Inj/Wound Repair,Init Encntr
 ;;^UTILITY(U,$J,358.3,40677,1,4,0)
 ;;=4^T81.33XA
 ;;^UTILITY(U,$J,358.3,40677,2)
 ;;=^5054476
 ;;^UTILITY(U,$J,358.3,40678,0)
 ;;=L60.3^^119^1742^30
 ;;^UTILITY(U,$J,358.3,40678,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40678,1,3,0)
 ;;=3^Dystrophic Nails
 ;;^UTILITY(U,$J,358.3,40678,1,4,0)
 ;;=4^L60.3
 ;;^UTILITY(U,$J,358.3,40678,2)
 ;;=^5009236
 ;;^UTILITY(U,$J,358.3,40679,0)
 ;;=M71.30^^119^1742^25
 ;;^UTILITY(U,$J,358.3,40679,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40679,1,3,0)
 ;;=3^Digital Mucous Cyst
 ;;^UTILITY(U,$J,358.3,40679,1,4,0)
 ;;=4^M71.30
 ;;^UTILITY(U,$J,358.3,40679,2)
 ;;=^5013149
 ;;^UTILITY(U,$J,358.3,40680,0)
 ;;=L30.4^^119^1743^9
 ;;^UTILITY(U,$J,358.3,40680,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40680,1,3,0)
 ;;=3^Erythema Intertrigo
 ;;^UTILITY(U,$J,358.3,40680,1,4,0)
 ;;=4^L30.4
 ;;^UTILITY(U,$J,358.3,40680,2)
 ;;=^5009157
 ;;^UTILITY(U,$J,358.3,40681,0)
 ;;=R60.0^^119^1743^6
 ;;^UTILITY(U,$J,358.3,40681,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40681,1,3,0)
 ;;=3^Edema,Localized
 ;;^UTILITY(U,$J,358.3,40681,1,4,0)
 ;;=4^R60.0
 ;;^UTILITY(U,$J,358.3,40681,2)
 ;;=^5019532
 ;;^UTILITY(U,$J,358.3,40682,0)
 ;;=L53.0^^119^1743^13
 ;;^UTILITY(U,$J,358.3,40682,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40682,1,3,0)
 ;;=3^Erythema Toxic
 ;;^UTILITY(U,$J,358.3,40682,1,4,0)
 ;;=4^L53.0
 ;;^UTILITY(U,$J,358.3,40682,2)
 ;;=^5009207
 ;;^UTILITY(U,$J,358.3,40683,0)
 ;;=L53.1^^119^1743^8
 ;;^UTILITY(U,$J,358.3,40683,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40683,1,3,0)
 ;;=3^Erythema Annulare Centrifugum
 ;;^UTILITY(U,$J,358.3,40683,1,4,0)
 ;;=4^L53.1
 ;;^UTILITY(U,$J,358.3,40683,2)
 ;;=^5009208
 ;;^UTILITY(U,$J,358.3,40684,0)
 ;;=L51.9^^119^1743^11
 ;;^UTILITY(U,$J,358.3,40684,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40684,1,3,0)
 ;;=3^Erythema Multiforme,Unspec
 ;;^UTILITY(U,$J,358.3,40684,1,4,0)
 ;;=4^L51.9
 ;;^UTILITY(U,$J,358.3,40684,2)
 ;;=^336759
 ;;^UTILITY(U,$J,358.3,40685,0)
 ;;=L12.35^^119^1743^7
 ;;^UTILITY(U,$J,358.3,40685,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40685,1,3,0)
 ;;=3^Epidermolysis Bullosa,Acquired
 ;;^UTILITY(U,$J,358.3,40685,1,4,0)
 ;;=4^L12.35
 ;;^UTILITY(U,$J,358.3,40685,2)
 ;;=^5009100
 ;;^UTILITY(U,$J,358.3,40686,0)
 ;;=L52.^^119^1743^12
 ;;^UTILITY(U,$J,358.3,40686,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40686,1,3,0)
 ;;=3^Erythema Nodosum
 ;;^UTILITY(U,$J,358.3,40686,1,4,0)
 ;;=4^L52.
 ;;^UTILITY(U,$J,358.3,40686,2)
 ;;=^42065
 ;;^UTILITY(U,$J,358.3,40687,0)
 ;;=L49.0^^119^1743^24
 ;;^UTILITY(U,$J,358.3,40687,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40687,1,3,0)
 ;;=3^Exfoliation d/t Erythematous Cond w/ < 10% Body Surface
 ;;^UTILITY(U,$J,358.3,40687,1,4,0)
 ;;=4^L49.0
 ;;^UTILITY(U,$J,358.3,40687,2)
 ;;=^5009190
 ;;^UTILITY(U,$J,358.3,40688,0)
 ;;=L49.1^^119^1743^15
 ;;^UTILITY(U,$J,358.3,40688,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40688,1,3,0)
 ;;=3^Exfoliation d/t Erythematous Cond w/ 10-19% Body Surface
 ;;^UTILITY(U,$J,358.3,40688,1,4,0)
 ;;=4^L49.1
 ;;^UTILITY(U,$J,358.3,40688,2)
 ;;=^5009191
 ;;^UTILITY(U,$J,358.3,40689,0)
 ;;=L49.2^^119^1743^16
 ;;^UTILITY(U,$J,358.3,40689,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40689,1,3,0)
 ;;=3^Exfoliation d/t Erythematous Cond w/ 20-29% Body Surface
 ;;^UTILITY(U,$J,358.3,40689,1,4,0)
 ;;=4^L49.2
 ;;^UTILITY(U,$J,358.3,40689,2)
 ;;=^5009192
 ;;^UTILITY(U,$J,358.3,40690,0)
 ;;=L49.3^^119^1743^17
 ;;^UTILITY(U,$J,358.3,40690,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40690,1,3,0)
 ;;=3^Exfoliation d/t Erythematous Cond w/ 30-39% Body Surface
 ;;^UTILITY(U,$J,358.3,40690,1,4,0)
 ;;=4^L49.3
 ;;^UTILITY(U,$J,358.3,40690,2)
 ;;=^5009193
 ;;^UTILITY(U,$J,358.3,40691,0)
 ;;=L49.4^^119^1743^18
 ;;^UTILITY(U,$J,358.3,40691,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40691,1,3,0)
 ;;=3^Exfoliation d/t Erythematous Cond w/ 40-49% Body Surface
 ;;^UTILITY(U,$J,358.3,40691,1,4,0)
 ;;=4^L49.4
 ;;^UTILITY(U,$J,358.3,40691,2)
 ;;=^5009194
 ;;^UTILITY(U,$J,358.3,40692,0)
 ;;=L49.5^^119^1743^19
 ;;^UTILITY(U,$J,358.3,40692,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40692,1,3,0)
 ;;=3^Exfoliation d/t Erythematous Cond w/ 50-59% Body Surface
 ;;^UTILITY(U,$J,358.3,40692,1,4,0)
 ;;=4^L49.5
 ;;^UTILITY(U,$J,358.3,40692,2)
 ;;=^5009195
 ;;^UTILITY(U,$J,358.3,40693,0)
 ;;=L49.6^^119^1743^20
 ;;^UTILITY(U,$J,358.3,40693,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40693,1,3,0)
 ;;=3^Exfoliation d/t Erythematous Cond w/ 60-69% Body Surface
 ;;^UTILITY(U,$J,358.3,40693,1,4,0)
 ;;=4^L49.6
 ;;^UTILITY(U,$J,358.3,40693,2)
 ;;=^5009196
 ;;^UTILITY(U,$J,358.3,40694,0)
 ;;=L49.7^^119^1743^21
 ;;^UTILITY(U,$J,358.3,40694,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40694,1,3,0)
 ;;=3^Exfoliation d/t Erythematous Cond w/ 70-79% Body Surface
 ;;^UTILITY(U,$J,358.3,40694,1,4,0)
 ;;=4^L49.7
